BiotechTube
Home/Innoblative Designs/Israel Madera
IM

Israel Madera

VP Marketing

Innoblative Designs

Therapeutic Areas

OncologySurgical Oncology

Innoblative Designs Pipeline

DrugIndicationPhase
SIRA® RFA Electrosurgical DeviceAdjunct for margin control in Breast-Conserving Surgery (Lumpectomy)Post-market
Platform DevicesSoft tissue diseases (Oncology)Development

Leadership Team at Innoblative Designs

RS
Richard Stark
Chief Executive Officer
AJ
Ariel Johnson
Chief Financial Officer
BR
Bob Rioux
Chief Technology Officer
KC
Katherine Crowley
VP Regulatory/Quality
AB
Alyssa Bailey
VP Operations
KP
Kelly Petrucci
VP Market Access
View full Innoblative Designs profile